Insufficient scRNA-seq data for expression of AKR1D1 at single-cell level.
Insufficient scRNA-seq data for expression of AKR1D1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 5271.47 | 226 / 226 | 85% | 51.17 | 345 / 406 |
adrenal gland | 74% | 7.68 | 191 / 258 | 7% | 0.30 | 16 / 230 |
thymus | 58% | 3.70 | 379 / 653 | 0% | 0.00 | 1 / 605 |
spleen | 47% | 6.40 | 113 / 241 | 0% | 0 | 0 / 0 |
breast | 34% | 5.71 | 156 / 459 | 4% | 0.45 | 47 / 1118 |
peripheral blood | 27% | 9.56 | 255 / 929 | 0% | 0 | 0 / 0 |
intestine | 25% | 1.45 | 237 / 966 | 1% | 0.13 | 4 / 527 |
prostate | 21% | 1.31 | 52 / 245 | 3% | 0.07 | 15 / 502 |
lung | 21% | 1.34 | 122 / 578 | 1% | 0.04 | 16 / 1155 |
stomach | 16% | 0.81 | 58 / 359 | 2% | 0.04 | 7 / 286 |
adipose | 15% | 1.10 | 177 / 1204 | 0% | 0 | 0 / 0 |
skin | 14% | 2.39 | 253 / 1809 | 0% | 0.00 | 2 / 472 |
blood vessel | 12% | 0.62 | 156 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 8% | 0.38 | 112 / 1445 | 3% | 0.31 | 6 / 183 |
kidney | 7% | 0.33 | 6 / 89 | 4% | 0.22 | 36 / 901 |
uterus | 6% | 0.55 | 11 / 170 | 1% | 0.01 | 3 / 459 |
ovary | 6% | 0.24 | 11 / 180 | 0% | 0 | 0 / 430 |
heart | 5% | 0.41 | 45 / 861 | 0% | 0 | 0 / 0 |
pancreas | 5% | 0.22 | 16 / 328 | 0% | 0 | 0 / 178 |
muscle | 4% | 0.20 | 30 / 803 | 0% | 0 | 0 / 0 |
brain | 3% | 0.14 | 80 / 2642 | 0% | 0.03 | 1 / 705 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.01 | 4 / 504 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006707 | Biological process | cholesterol catabolic process |
GO_0006699 | Biological process | bile acid biosynthetic process |
GO_0008209 | Biological process | androgen metabolic process |
GO_0030573 | Biological process | bile acid catabolic process |
GO_0008207 | Biological process | C21-steroid hormone metabolic process |
GO_0007586 | Biological process | digestion |
GO_0005829 | Cellular component | cytosol |
GO_0016229 | Molecular function | steroid dehydrogenase activity |
GO_0047787 | Molecular function | Delta4-3-oxosteroid 5beta-reductase activity |
GO_0047086 | Molecular function | ketosteroid monooxygenase activity |
GO_0004033 | Molecular function | aldo-keto reductase (NADPH) activity |
GO_0004032 | Molecular function | aldose reductase (NADPH) activity |
GO_0005496 | Molecular function | steroid binding |
Gene name | AKR1D1 |
Protein name | Aldo-keto reductase family 1 member D1 Aldo-keto reductase family 1, member D1 (EC 1.3.99.6) Aldo-keto reductase family 1 member D1 (EC 1.3.1.3) (3-oxo-5-beta-steroid 4-dehydrogenase) (Delta(4)-3-ketosteroid 5-beta-reductase) (Delta(4)-3-oxosteroid 5-beta-reductase) |
Synonyms | SRD5B1 |
Description | FUNCTION: Catalyzes the stereospecific NADPH-dependent reduction of the C4-C5 double bond of bile acid intermediates and steroid hormones carrying a delta(4)-3-one structure to yield an A/B cis-ring junction. This cis-configuration is crucial for bile acid biosynthesis and plays important roles in steroid metabolism. Capable of reducing a broad range of delta-(4)-3-ketosteroids from C18 (such as, 17beta-hydroxyestr-4-en-3-one) to C27 (such as, 7alpha-hydroxycholest-4-en-3-one). . |
Accessions | ENST00000242375.8 [P51857-1] ENST00000432161.5 [P51857-2] C4PL37 P51857 ENST00000411726.6 [P51857-3] C4PL36 C9J3U1 C4PL35 ENST00000438242.1 |